Chargement en cours...
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
OBJECTIVE: This study was performed to evaluate the efficacy of daily subcutaneous enoxaparin 20 mg in patients with renal failure. METHODS: This retrospective cohort study included nonsurgical patients aged ≥18 years with a creatinine clearance rate of <30 mL/minute who were prescribed enoxapari...
Enregistré dans:
| Publié dans: | J Int Med Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6384464/ https://ncbi.nlm.nih.gov/pubmed/30259770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060518799896 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|